Aptevo CEO converts 961 RSUs into common stock
Aptevo Therapeutics Inc. reported that President and CEO Jeffrey G. Lamothe exercised 961 Restricted Stock Units on August 6, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. reported that President and CEO Jeffrey G. Lamothe exercised 961 Restricted Stock Units on August 6, 2026. The RSUs converted on a one-for-one basis into 961 shares of common stock, which he now holds directly. The derivative RSU position was reduced to zero in this filing.
Insider Trade Summary
961 shares exercised/converted
Exercise
2 txns
Insider
Lamothe Jeffrey G.
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 961 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 961 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 units (Direct);
Common Stock — 961 shares (Direct)
Footnotes (2)
- F1. Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- F2. On August 6, 2025, the reporting person was granted 17,300 (961 post-split) RSUs, vesting on the first anniversary of the date of grant.
Key Figures
RSUs exercised: 961.0000 shares
Common shares acquired: 961.0000 shares
RSU grant (pre-split / post-split): 17,300 (961 post-split) RSUs
3 metrics
RSUs exercised
961.0000 shares
Restricted Stock Units converted into common stock on August 6, 2026
Common shares acquired
961.0000 shares
Common stock received from RSU conversion; direct ownership
RSU grant (pre-split / post-split)
17,300 (961 post-split) RSUs
Grant on August 6, 2025, vesting on first anniversary of grant date
Key Terms
Restricted Stock Unit, one-for-one basis, post-split, derivative security
4 terms
Restricted Stock Unit financial
"Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
one-for-one basis financial
"RSUs convert into common stock on a one-for-one basis"
post-split financial
"granted 17,300 (961 post-split) RSUs, vesting on the first anniversary"
derivative security financial
"transaction code description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Aptevo Therapeutics (APVO) report for Jeffrey G. Lamothe?
Aptevo Therapeutics reported that Jeffrey G. Lamothe exercised 961 RSUs on August 6, 2026, which converted into 961 shares of common stock. The transaction reflects a derivative exercise, not an open-market purchase or sale.
How many Aptevo Therapeutics (APVO) RSUs did the CEO convert to common stock?
Jeffrey G. Lamothe converted 961 Restricted Stock Units into 961 shares of common stock. The RSUs convert on a one-for-one basis into Aptevo Therapeutics common stock, $0.001 par value per share.
What was Jeffrey G. Lamothe’s resulting Aptevo (APVO) common stock holding from this Form 4?
Following the reported transactions, Jeffrey G. Lamothe directly held 961 shares of Aptevo common stock from this RSU conversion. The corresponding derivative RSU position reported in this filing was reduced to zero.
Were any cash proceeds or sale transactions reported in this Aptevo (APVO) Form 4?
No sale was reported. The Form 4 shows an exercise of RSUs into 961 common shares at a reported $0.0000 per share for the derivative, with no accompanying sale transaction disclosed in this data.
What do the footnotes in the Aptevo (APVO) Form 4 say about the RSU grant?
The footnotes state that RSUs convert into common stock on a one-for-one basis and that on August 6, 2025, Lamothe was granted 17,300 RSUs (961 post-split), vesting on the first anniversary of the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
